Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Gallbladder Neoplasms × ARRY-334543 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Neoplasms 1 Gallbladder Neoplasms 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1

Interventions

Gemcitabine 3 Cisplatin 3 Oxaliplatin 2 durvalumab 1 Standard of Care 1 Geriatric Assessment 1 Everolimus 1 Drug Therapy 1 Capecitabine 1 ARRY-334543 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03093870 2021-08-03

TreeTopp

ASLAN Pharmaceuticals

Phase 2/3 Completed

151 enrolled 18 charts

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡